BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38309198)

  • 21. Unmet Needs and Perspectives in Oral Cancer Prevention.
    Bouaoud J; Bossi P; Elkabets M; Schmitz S; van Kempen LC; Martinez P; Jagadeeshan S; Breuskin I; Puppels GJ; Hoffmann C; Hunter KD; Simon C; Machiels JP; Grégoire V; Bertolus C; Brakenhoff RH; Koljenović S; Saintigny P
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
    Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
    Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of autofluorescence in diagnosing oral squamous cell carcinoma and oral potentially malignant disorders: a comparative study with aero-digestive lesions.
    Luo X; Xu H; He M; Han Q; Wang H; Sun C; Li J; Jiang L; Zhou Y; Dan H; Feng X; Zeng X; Chen Q
    Sci Rep; 2016 Jul; 6():29943. PubMed ID: 27416981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer in buccal mucosa in patients with Fanconi anemia: Report of six cases.
    Mattos da Silva PQ; Ballardin BS; Torres-Pereira CC
    Spec Care Dentist; 2024; 44(2):472-477. PubMed ID: 37400941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide.
    Yap T; Celentano A; Seers C; McCullough MJ; Farah CS
    J Oral Pathol Med; 2020 Jan; 49(1):1-8. PubMed ID: 31309636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of protein-based salivary markers in the diagnosis of oral potentially malignant disorders: A systematic review and meta-analysis.
    Arroyo E; Donís SP; Petronacci CMC; Alves MGO; Mendía XM; Fernandes D; Pouso AIL; Bufalino A; Bravo López S; Sayáns MP
    Cancer Biomark; 2021; 32(4):411-424. PubMed ID: 34334380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review.
    Syrjänen S; Lodi G; von Bültzingslöwen I; Aliko A; Arduino P; Campisi G; Challacombe S; Ficarra G; Flaitz C; Zhou HM; Maeda H; Miller C; Jontell M
    Oral Dis; 2011 Apr; 17 Suppl 1():58-72. PubMed ID: 21382139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant transformation rate of oral leukoplakia in an Australian population.
    Shearston K; Fateh B; Tai S; Hove D; Farah CS
    J Oral Pathol Med; 2019 Aug; 48(7):530-537. PubMed ID: 31172563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Salivary Electrolytes Profile in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Saavedra JA; Novo DR; Mesko MF; Uchoa Vasconcellos AC; Duarte Da Silva K; Rojas Zuñiga G; Ramires RF; Tarquinio SBC
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):1031-1039. PubMed ID: 35345377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
    S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
    Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma.
    Errazquin R; Carrasco E; Del Marro S; Suñol A; Peral J; Ortiz J; Rubio JC; Segrelles C; Dueñas M; Garrido-Aranda A; Alvarez M; Belendez C; Balmaña J; Garcia-Escudero R
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.
    Dionne KR; Warnakulasuriya S; Zain RB; Cheong SC
    Int J Cancer; 2015 Feb; 136(3):503-15. PubMed ID: 24482244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of the XRCC1 rs25487 polymorphism with demographic, behavioral, clinical, and histological parameters in oral potentially malignant disorders and oral squamous cell carcinoma in a Colombian population.
    Hernández-Arenas YY; Támara-De Ávila JJ; Isaza-Guzmán DM; González-Pérez LV; Tobón-Arroyave SI
    J Oral Biosci; 2021 Jun; 63(2):217-223. PubMed ID: 33647453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis.
    Bates T; Kennedy M; Diajil A; Goodson M; Thomson P; Doran E; Farrimond H; Thavaraj S; Sloan P; Kist R; Robinson M
    Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):927-35. PubMed ID: 27197272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.
    Lin SC; Liu CJ; Ji SH; Hung WW; Liu YC; Chang SR; Tu HF; Chang KW
    Clin Oral Investig; 2022 Feb; 26(2):1343-1351. PubMed ID: 34342761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral squamous cell carcinoma arising from chronic traumatic ulcers.
    Gilligan G; Piemonte E; Lazos J; Simancas MC; Panico R; Warnakulasuriya S
    Clin Oral Investig; 2023 Jan; 27(1):193-201. PubMed ID: 36088397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the lesion surface suggesting transformation of oral potentially malignant disorders to malignancy - a report of eight cases.
    Kim MJ; Kho HS
    BMC Oral Health; 2023 May; 23(1):268. PubMed ID: 37161457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders.
    Li H; Liu Y; Zhou S; Zhou Q; Yang X
    BMC Oral Health; 2023 Sep; 23(1):659. PubMed ID: 37697274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a Gene-Expression-Based Surrogate of Genomic Instability during Oral Carcinogenesis.
    Truchard E; Bertolus C; Martinez P; Thomas E; Saintigny P; Foy JP
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.